Telesis Bio, Inc. (NASDAQ:TBIO) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2, 2023 Telesis Bio Earnings Conference Call. At this time, all participants are in listen-only mode.
Translate Bio Inc. (TBIO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 0 | $0 | -100% | 0% |
| 2. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 0 | $0 | -100% | 0% |
| 3. | Ancora Advisors Frederick Disanto | 0 | $0 | -100% | 0% |
| 4. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 0 | $0 | -100% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.00 | 20,515,985 | Large Shareholder | 75,668,031 | 2021-09-14 | Filing | |
| $38.00 | 51,467,612 | Large Shareholder | 55,152,046 | 2021-09-14 | Filing | |
| $22.00 | 500,000 | Large Shareholder | 18,044,239 | 2020-06-26 | Filing | |
| $13.00 | 269,230 | Director | 3,697,912 | 2018-07-02 | Filing | |
| $13.00 | 25,000 | Large Shareholder | 1,873,503 | 2018-07-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.00 | 40,909 | Officer, Director | 0 | 2021-09-14 | Filing | |
| $38.00 | 409,913 | Officer, Director | 0 | 2021-09-14 | Filing | |
| $38.00 | 503,231 | Officer, Director | 0 | 2021-09-14 | Filing | |
| $38.00 | 71,833 | Officer, Other | 0 | 2021-09-14 | Filing | |
| $38.00 | 29,860 | Director | 0 | 2021-09-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
Telesis Bio, Inc. (NASDAQ:TBIO) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by, and welcome to the Q4 2022 Telesis Bio Earnings Conference Call. .
Seth Klarman's Portfolio: Top 10 Stock Picks
In this article we will take a look at the top 10 stock picks in Seth Klarman's portfolio.
Is Translate Bio, Inc. (TBIO) Going to Burn These Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
5 Best Defensive Stocks to Buy Now
Below is the list of the 5 best defensive stocks to buy now, according to Baupost Group co-founder Seth Klarman.
Billionaire Seth Klarman's Top 10 Stock Picks for 2021
In this article, we discussed billionaire Seth Klarman's top 10 stock picks for 2021.
Hedge Funds Have Never Been This Bullish On Translate Bio, Inc. (TBIO)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Are Selling Translate Bio, Inc. (TBIO)
In this article we will take a look at whether hedge funds think Translate Bio, Inc. (NASDAQ:TBIO) is a good investment right now.
Translate Bio, Inc. (TBIO): Are Hedge Funds Right About This Stock?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
Is Translate Bio, Inc. (TBIO) Going To Burn These Hedge Funds ?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Billionaire Hedge Funds
